(Q35808818)

10 August 2017

1 reference

title

Anti-HLA antibody analysis and crossmatching in heart and lung transplantation (English)

1 reference

10 August 2017

1 reference

3

Adriana Zeevi

1 reference

10 August 2017

Nancy L Reinsmoen

1

1 reference

10 August 2017

Karen Nelson

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 June 2004

1 reference

10 August 2017

published in

Transplant Immunology

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

63-71

1 reference

Pre-Transplant Assessment of Donor-Reactive, HLA-Specific Antibodies in Renal Transplantation: Contraindication vs. Risk

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Significance of the positive crossmatch test in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Anti-HLA antibodies after solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Unilateral lung transplantation for pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Immunomodulation of kidney and heart transplants by anti-idiotypic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Flow panel reactive antibody monitoring following heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Hyperacute rejection following lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Hyperacute rejection in single lung transplantation--case report of successful management by means of plasmapheresis and antithymocyte globulin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Immunologic monitoring in lung allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Anti-endothelial antibodies and coronary artery disease after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Use of C4d as a diagnostic adjunct in lung allograft biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Association of humoral immunity and bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

Isolation of precursor endothelial cells from peripheral blood for donor-specific crossmatching before organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.01.005

10.1016/J.TRIM.2004.01.005

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference